Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin + doxycycline versus doxycycline + rifampin for brucellosis
IRCT20180817040819N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in brucellosis comparing Levofloxacin + doxycycline with Doxycycline + rifampin (2 arms). Primary endpoints: fever, body pain and 6 more. Started Dec 2018; status: completed.
02
Drugs
levofloxacindoxycyclinerifampicin
03
Conditions
brucellosis
Beyond the preview
Go deeper on IRCT20180817040819N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180817040819N1.